2014 Annual Meeting | Neuro-Oncology

Date Tuesday 04/29/14

Time 03:15 PM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Topic(s) Neuro-oncology

CME Available No CME available

Event Timeline
03:15 PM - 05:00 PM	Abstract	001 - A vaccine targeting mutant IDH1 induces antitumor immunity Michael Platten, MD
03:15 PM - 05:00 PM	Abstract	002 - Neurocognitive Function (NCF) Substudy and Mini-Mental State Examination (MMSE) Results from the Randomized, Placebo-Controlled Phase III AVAglio Trial of Bevacizumab (BEV) Added to Radiotherapy (RT) and Temozolomide (TMZ) for Newly Diagnosed Glioblastoma Jeffrey S Wefel
03:15 PM - 05:00 PM	Abstract	003 - Overview of Arterial Thromboembolic Events (ATEs) in AVAglio, a Randomized, Placebo-controlled Phase III Trial of Bevacizumab, Radiotherapy and Temozolomide (BEV+RT/TMZ) for Newly Diagnosed Glioblastoma Warren P. Mason, MD, FAAN
03:15 PM - 05:00 PM	Abstract	004 - Predicting progressive gangliogliomas: early identification of those at risk in a sample of 156 consecutive patients treated at the Barrow Neurological Institute Glynnis Zieman, MD, MPH, FAAN
03:15 PM - 05:00 PM	Abstract	005 - The Neurologic Assessment in Neuro-Oncology (NANO) Scale: A Tool to Assess Neurologic Function for Integration in the Radiologic Assessment in Neuro-Oncology (RANO) Criteria Lakshmi Nayak, MD
03:15 PM - 05:00 PM	Abstract	006 - Improved progression free survival in 1p/19q co-deleted anaplastic oligodendroglioma treated with both chemotherapy and radiation therapy at diagnosis Jacob Mandel, MD
03:15 PM - 05:00 PM	Abstract	007 - Ionizing Radiation Arrests Subventricular Zone Neural Precursors in G2/M without Affecting Long-Term Self-Renewal

Faculty Disclosures
Jaishri Blakeley, MD, FAAN	Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Lisa R. Rogers, DO, FAAN	Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Patrick Y. Wen, MD, FAAN	Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nuvation Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prelude Therapeutics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for VBI Vaccines . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Black Diamond . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celularity. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Bio . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Glaxo Smith Kline . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mundipharma. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Nuvation Bio. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sagimet. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sapience. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vascular Biogenics . Dr. Wen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines . Dr. Wen has received research support from Astra Zeneca . Dr. Wen has received research support from Black Diamond . Dr. Wen has received research support from Bristol Meyers Squibb . Dr. Wen has received research support from Celgene. Dr. Wen has received research support from Chimerix. Dr. Wen has received research support from Eli Lily . Dr. Wen has received research support from Erasca. Dr. Wen has received research support from Genentech/Roche . Dr. Wen has received research support from Kazia . Dr. Wen has received research support from MediciNova. Dr. Wen has received research support from Merck. Dr. Wen has received research support from Novartis. Dr. Wen has received research support from Nuvation Bio . Dr. Wen has received research support from Servier. Dr. Wen has received research support from Vascular Biogenics . Dr. Wen has received research support from VBI Vaccines . Dr. Wen has received publishing royalties from a publication relating to health care.
Lakshmi Nayak, MD	Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceutical. An immediate family member of Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BraveBio. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kite/Gilead. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genmab. Dr. Nayak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono. Dr. Nayak has received publishing royalties from a publication relating to health care.
Kurt A. Jaeckle, MD, FAAN	Dr. Jaeckle has stock in Entegrion, Inc.
Martin Van Den Bent	Martin Van Den Bent has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genenta. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fore Biotherapeutics. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Incyte. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier. Martin Van Den Bent has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for European Journal of Cancer. Martin Van Den Bent has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuro-Oncology.
	No disclosure on file
Warren P. Mason, MD, FAAN	Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mason has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boeringher Ingelheim. Dr. Mason has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Therapeutics.
Lisa M. DeAngelis, MD, FAAN	Dr. DeAngelis has nothing to disclose.
Riccardo Soffietti, MD	Dr. Soffietti has nothing to disclose.
James R. Perry, MD, FRCP(C), FAAN	The institution of Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Enveric Biosciences . The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Canadian Brain Tumour Consortium. Dr. Perry has stock in Synaptive Medical.
Lynn S. Ashby, MD	Dr. Ashby has nothing to disclose.
Marc Chamberlain, MD	No disclosure on file
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
David Reardon	No disclosure on file
Evanthia Galanis	No disclosure on file
Christopher Dardis, MD	No disclosure on file
David R. Macdonald, MD	No disclosure on file
Joseph A. Garcia, MD	No disclosure on file
Michael Platten, MD	No disclosure on file
Wolfgang Wick	The institution of Wolfgang Wick has received research support from Roche. The institution of Wolfgang Wick has received research support from Pfizer. The institution of Wolfgang Wick has received research support from Apogenix.
Manuel Alexander Friese, MD	No disclosure on file
John F. De Groot, MD	An immediate family member of Dr. De Groot has received personal compensation for serving as an employee of Ziopharm Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Deciphera Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for FivePrime Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Carthera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadmon. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Biomedical Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Taiho Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kairos Venture Investments. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Syneos Health. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Monteris. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Agios. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mundipharma Research. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GenomiCare. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Del Mar Pharmaceuticals. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Tocagen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bioasis Technologies, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ResTORbio, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celldex. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Foundation Medicine, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novogen. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Deciphera. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insys Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck & Co.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lily. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella Clinical. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karyopharm Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Blue Earth Diagnostics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiyatec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vanquish Oncology. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orsenix, Insightec. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prelude Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Debiopharm Therapeutics, Inc.. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Global Services, LLC. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBL Therapeutics. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novella. Dr. De Groot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VBI Vaccines, Inc.. An immediate family member of Dr. De Groot has received stock or an ownership interest from Ziopharm Oncology. An immediate family member of Dr. De Groot has received stock or an ownership interest from Gilead. The institution of Dr. De Groot has received research support from Carthera. The institution of Dr. De Groot has received research support from HaiHe Pharma. The institution of Dr. De Groot has received research support from Taiho Pharma.
Jacob Mandel, MD	No disclosure on file
W K A. Yung, MD, FAAN	No disclosure on file
Andreas von Deimling	No disclosure on file
Adam J. Simon, PhD	No disclosure on file
Jeffrey S Wefel	No disclosure on file
Glynnis Zieman, MD, MPH, FAAN	Dr. Zieman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Football League.
Timothy F. Cloughesy, MD	Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BlueRock. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vida Ventures. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lista Therapeutics. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stemline. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sonalasense. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Servier. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sagimet. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jubilant. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gan & Lee. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainstorm. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sapience. Dr. Cloughesy has received personal compensation in the range of $0-$499 for serving as a Consultant for Inovio. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DNATrix. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tyme. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kintara. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer Ingelheim. Dr. Cloughesy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Cloughesy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Katmai. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Break Through Cancer. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kintara. Dr. Cloughesy has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chimerix. Dr. Cloughesy has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Katmai. Dr. Cloughesy has stock in Katmai. Dr. Cloughesy has stock in Chimerix. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care. Dr. Cloughesy has received intellectual property interests from a discovery or technology relating to health care.
Serge G. Gauthier, MD	Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Kenneth J. Shulman, DO	No disclosure on file